IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest 20-F/A SEC Filings
Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]

TRINITY BIOTECH PLC, 20-F/A, 2000-04-05
BIOCHEM PHARMA INC, 20-F/A, 1998-06-03
BIOCHEM PHARMA INC, 20-F/A, 1998-05-27


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission